Englebert Financial Advisers LLC Acquires Shares of 8,469 GE HealthCare Technologies Inc. $GEHC

Englebert Financial Advisers LLC acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,469 shares of the company’s stock, valued at approximately $695,000. GE HealthCare Technologies accounts for approximately 0.8% of Englebert Financial Advisers LLC’s investment portfolio, making the stock its 26th largest holding.

Several other institutional investors also recently bought and sold shares of GEHC. Godsey & Gibb Inc. acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the period. Finally, Maseco LLP acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth approximately $29,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other GE HealthCare Technologies news, Director Watkin Phoebe L. Yang bought 1,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 8th. The shares were bought at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The stock was acquired at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased 10,229 shares of company stock worth $619,190 over the last ninety days. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $61.70 on Tuesday. The stock’s fifty day moving average is $71.06 and its two-hundred day moving average is $77.15. The firm has a market capitalization of $28.07 billion, a P/E ratio of 14.76, a price-to-earnings-growth ratio of 1.43 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same period last year, the firm posted $1.01 EPS. The business’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on GEHC. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Rothschild & Co Redburn lowered their price target on GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Mizuho lowered their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. JPMorgan Chase & Co. lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Finally, BNP Paribas Exane lowered their price target on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus price target of $80.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.